ROSSI EMANUELA

Role
Administrative-Technical Staff  
Office phone

Publications

  • Hertz, D., Tanay, M., Tofthagen, C., Rossi, E., Bernasconi, D., Sheffield, K., et al. (2025). Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy. SUPPORTIVE CARE IN CANCER, 33(2) [10.1007/s00520-025-09190-6]. Detail

  • Hertz, D., Tofthagen, C., Rossi, E., Bernasconi, D., Lim, J., Carlson, M., et al. (2024). Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. SUPPORTIVE CARE IN CANCER, 32(1 (January 2024)) [10.1007/s00520-023-08209-0]. Detail

  • Fimognari, F., Tassistro, E., Rossi, E., Bambara, V., Valsecchi, M., Cherubini, A., et al. (2024). The Interplay among Respiratory Failure, Delirium, Frailty and Severity of Illness in Hospitalized Older Medical Patients: A Nationwide Multicenter Observational Study. THE JOURNAL OF FRAILTY & AGING, 13(4 (November 2024)), 480-486 [10.14283/jfa.2024.12]. Detail

  • Faverio, P., Paciocco, G., Tassistro, E., Rebora, P., Rossi, E., Monzani, A., et al. (2024). Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study. INTERNAL AND EMERGENCY MEDICINE, 19(1 (January 2024)), 183-190 [10.1007/s11739-023-03400-x]. Detail

  • Soria, A., Graziano, F., Ghilardi, G., Lapadula, G., Gasperina, D., Benatti, S., et al. (2024). Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort. HELIYON, 10(16) [10.1016/j.heliyon.2024.e36102]. Detail